
Dermatology beyond the skin | LEO Pharma
LEO Pharma delivers double-digit revenue growth and strong progress for strategic transformation 2024 was a year of strong progress for LEO Pharma with double-digit growth in sales and another year of significantly improved EBITDA.
Who we are - LEO Pharma
The LEO Foundation is one of Denmark’s largest commercial foundations and an engaged owner of the pharmaceutical company LEO Pharma.
Jobs | LEO Pharma
We are constantly searching for new colleagues who share our passion and ambition. With the right people on board, LEO Pharma can continue to make a fundamental difference for those who need us most in medical dermatology.
Your career - LEO Pharma
At LEO Pharma, we help people with skin diseases live fulfilling lives by advancing dermatology beyond the skin. Learn more about our available job opportunities and life at LEO Pharma here.
View our pipeline | LEO Pharma
LEO Pharma is developing an even deeper understanding of hard-to-treat skin diseases by forging external partnerships with innovators while we evolve our current offerings
Our science - LEO Pharma
From our earliest history, LEO Pharma has gone beyond conventional approaches to serve patients and meet their needs. Today we remain committed to making a fundamental difference for those who need us most in medical dermatology.
2025 Annual results 2024 - LEO Pharma
Feb 26, 2025 · Over 2024, LEO Pharma made significant progress, delivering another year of double-digit sales growth, advancing our innovation agenda with the approval and launch of Anzupgo®, and optimizing our operations with a strong emphasis on disciplined capital allocation.
Our heritage | LEO Pharma
Today, LEO Pharma is stronger than ever with a growing global presence, a dedicated work force of more than 4,700 specialists and a strong pipeline of unrivalled pharmaceutical products within dermatology and thrombosis.
Our annual reporting | LEO Pharma
LEO Pharma’s performance last year puts it on track to meet its ambitions for sustainable, profitable growth and innovation, as set out in 2021, when the company embarked on a multi-year transformation strategy anchored in three areas: growth, pipeline and profitability.
What we stand for | LEO Pharma
LEO Pharma A/S. Industriparken 55 DK-2750 Ballerup Denmark. Tel. +45 4494 5888 CVR No. 56759514. FOLLOW US. X (Twitter) LinkedIn; Facebook; YouTube ...